This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

June 16–17, 2020
Hyatt Regency San Francisco Airport,
Burlingame, CA

Achieve Excellence in Financial Planning, Forecasting, Gross-to-Net, Corporate Controllership and External Reporting

For CFOs, Corporate Controllers and Finance/Accounting Teams of High Growth Life Science Companies to Discuss Effectively Scaling the Business and Remaining Compliant with External Reporting.

Take Advantage of our Advanced Pricing Discount...

Register by March 6, 2020 and Save $400!

What to Expect

Up to the Minute Insight on New Accounting & Reporting Rules

SEC updates on key priorities, industry trends and focal areas

Tax strategies for R&D expenditures based on the Tax Cuts and Jobs Act

 2022 requirements to capitalize and amortize all R&D expenditures based on domestic or foreign spending

 Cybersecurity, fraud and data privacy considerations for CFOs

Emerging regulations for data privacy in the U.S. that are emulating GDPR style policies

Industry Specific CPE Content and Life Science Company Benchmarking

3 In-Depth Workshops:

  • Life Science Industry Bootcamp
  • Commercialization of New Products
  • Symposium for Senior Industry Executives

High-Impact Topics Include:

Digital Finance • Revenue Recognition • Corporate Tax Reform Gross-to-Net Accruals • Forecasting Management • Product Launch Planning • ERP Implementation & Optimization • Cybersecurity & Fraud • Funding Models • Post-IPO Strategies • and More

Customizable Learning for Clinical or Commercial Stage Companies

Spotlight on Clinical Stage

  • IPO preparation plan and SEC reporting 
  • Third-party risk and oversight 
  • CRO and clinical outsourcing frameworks 
  • Validating the company valuation

Successful Strategies for Commercial Stage

  • Successful product launch strategies
  • Product pricing dynamics
  • Risk advisory and SOX 
  • GTN models and best practices


Annual Audience Consists of:

73%
Accounting/Finance
15%
Controllers
5%
CFO/CAO
2%
Audit
2%
Compliance
2%
Contracts/Pricing
1%
Business Analysis

Connect with Key Decision-Makers at Finance & Accounting for Bioscience Companies


Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, contact LifeSciencePartners@informaconnectls.com.